This HTML5 document contains 66 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38197665
rdf:type
wikibase:Item
schema:description
vedecký článok artigo científico artikull shkencor artigo científico vitskapeleg artikkel artículo científico bài báo khoa học научни чланак artigo científico научная статья article scientifique article científic artículu científicu espublizáu en 2013 مقالة علمية نشرت في أكتوبر 2013 articolo scientifico vitenskapelig artikkel wissenschaftlicher Artikel מאמר מדעי наукова стаття, опублікована в жовтні 2013 bilimsel makale vetenskaplig artikel wetenschappelijk artikel বৈজ্ঞানিক নিবন্ধ artikel ilmiah scientific article published on October 2013 articol științific scienca artikolo scientific article published on October 2013 videnskabelig artikel vědecký článek scientific article published on October 2013
p:P577
wds:Q38197665-40B3B41C-28FC-4E2D-BD68-9BA65DF5A145
wdt:P577
2013-10-01T00:00:00Z
p:P2093
wds:Q38197665-CFCFFE2B-DA01-4348-B5B9-6B3DA6E70B45 wds:Q38197665-198DD40B-7F3B-4B2A-A403-43BBDC757019 wds:Q38197665-23338529-EC1F-4B41-B666-ED0C511CBD84
wdt:P2093
Vitaly Soskin Deepak Gupta Carl Christensen
rdfs:label
Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients? Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients? Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients?
skos:prefLabel
Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients? Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients? Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients?
schema:name
Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients? Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients? Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients?
p:P1476
wds:Q38197665-9296C57A-19BB-4C98-9C08-D4E5731432E7
wdt:P1476
Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients?
p:P304
wds:Q38197665-6354E06A-A24B-4F42-BC3E-4B4B137FFCCD
wdt:P304
273-281
p:P31
wds:Q38197665-5D248317-51ED-4FF4-9CC4-453C51F39F5B
wdt:P31
wd:Q13442814
p:P921
wds:Q38197665-9d4a043e-e98f-4dd4-aa67-3100d0cbedf5
wdt:P921
wd:Q427523
p:P698
wds:Q38197665-37F94FA5-7396-464D-A660-A5DC70BC013A
wdtn:P698
n11:24649783
wdt:P698
24649783
p:P1433
wds:Q38197665-9B679FCA-CDBE-43FD-931E-BC0A5B12905F
wdt:P1433
wd:Q27712012
p:P433
wds:Q38197665-D87026FB-67AE-483B-B3D3-DC400D587FE6
p:P478
wds:Q38197665-E8A05609-4F85-4EB3-BE13-585809B640D9
wdt:P433
3
wdt:P478
22